Stock CLPT CLEARPOINT NEURO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings ClearPoint Neuro, Inc.

Equities

CLPT

US18507C1036

Market Closed - Nasdaq
Other stock markets
 21:00:00 02/05/2024 BST 		5-day change 1st Jan Change
5.52 USD +1.85% Intraday chart for ClearPoint Neuro, Inc. +3.76% -18.70%
04-30 Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory MT
04-29 ClearPoint Gets FDA Clearance For Neurosurgical Equipment MT

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CLEARPOINT NEURO, INC. Stock ClearPoint Neuro, Inc.
-18.70% 147M -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.62% 219B
B
DANAHER CORPORATION Stock Danaher Corporation
+6.70% 183B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.94% 132B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+24.60% 106B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-2.66% 62.09B
A-
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.88B
B+
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+11.55% 50.8B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-1.09% 40.64B
A
RESMED, INC. Stock ResMed, Inc.
+26.82% 31.59B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CLPT Stock
  4. Ratings ClearPoint Neuro, Inc.